chr7-94426787-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.3106-221A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 626,086 control chromosomes in the GnomAD database, including 5,412 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1034 hom., cov: 31)
Exomes 𝑓: 0.13 ( 4378 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.63

Publications

7 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 7-94426787-A-G is Benign according to our data. Variant chr7-94426787-A-G is described in ClinVar as Benign. ClinVar VariationId is 1221203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.3106-221A>G intron_variant Intron 46 of 51 ENST00000297268.11 NP_000080.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.3106-221A>G intron_variant Intron 46 of 51 1 NM_000089.4 ENSP00000297268.6

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16384
AN:
152064
Hom.:
1033
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0594
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.0583
Gnomad ASJ
AF:
0.0817
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.203
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.128
Gnomad OTH
AF:
0.0750
GnomAD4 exome
AF:
0.129
AC:
60996
AN:
473904
Hom.:
4378
Cov.:
5
AF XY:
0.131
AC XY:
33179
AN XY:
253080
show subpopulations
African (AFR)
AF:
0.0612
AC:
785
AN:
12828
American (AMR)
AF:
0.0716
AC:
1414
AN:
19752
Ashkenazi Jewish (ASJ)
AF:
0.0700
AC:
998
AN:
14248
East Asian (EAS)
AF:
0.137
AC:
4300
AN:
31498
South Asian (SAS)
AF:
0.168
AC:
7713
AN:
45838
European-Finnish (FIN)
AF:
0.184
AC:
5593
AN:
30420
Middle Eastern (MID)
AF:
0.0514
AC:
106
AN:
2062
European-Non Finnish (NFE)
AF:
0.128
AC:
37137
AN:
290236
Other (OTH)
AF:
0.109
AC:
2950
AN:
27022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2817
5633
8450
11266
14083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.108
AC:
16401
AN:
152182
Hom.:
1034
Cov.:
31
AF XY:
0.110
AC XY:
8148
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0595
AC:
2470
AN:
41536
American (AMR)
AF:
0.0583
AC:
892
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0817
AC:
283
AN:
3466
East Asian (EAS)
AF:
0.116
AC:
600
AN:
5178
South Asian (SAS)
AF:
0.176
AC:
847
AN:
4816
European-Finnish (FIN)
AF:
0.203
AC:
2148
AN:
10572
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.128
AC:
8735
AN:
67994
Other (OTH)
AF:
0.0780
AC:
165
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
743
1486
2230
2973
3716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
733
Bravo
AF:
0.0942
Asia WGS
AF:
0.151
AC:
525
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
20
DANN
Benign
0.83
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7804898; hg19: chr7-94056099; API